References
- PooleKResistance to β-lactam antibioticsCell Mol Life Sci2004612200222315338052
- DrawzSMBonomoRThree decades of β-lactamase inhibitorsClin Microbiol Rev20102316020120065329
- StachyraTPéchereauMCBruneauJMMechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-β-lactam β-lactamase inhibitorAntimicrob Agents Chemother2010545132513820921316
- EhmannDEJahićHRossPLAvibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitorProc Natl Acad Sci U S A2012109116631166822753474
- BonnefoyADupuis-HamelinCSteierVIn vitro activity of AVE1330A, an innovative broad-spectrum non-β-lactam β-lactamase inhibitorJ Antimicrob Chemother20045441041715254025
- LivermoreDMMushtaqSWarnerMMiossecCWoodfordNNXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum β-lactamases and carbapenemasesJ Antimicrob Chemother2008621053105618689875
- StachyraTLevasseurPPéchereauMCIn vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemasesJ Antimicrob Chemother20096432632919493866
- JonesRNImportant and emerging β-lactamase-mediated resistances in hospital-based pathogens: the AmpC enzymesDiagn Microbiol Infect Dis1998314614669635237
- JacobyGAAmpC β-lactamasesClin Microbiol Rev20092216118219136439
- KitzisMDFerréBCoutrotAIn vitro activity of combinations of β-lactam antibiotics with β-lactamase inhibitors against cephalosporinase-producing bacteriaEur J Clin Microbiol Infect Dis198987837882556277
- ListerPDGardnerVMSandersCCClavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillinAntimicrob Agents Chemother19994388288910103195
- SandersCCSandersWEJrGoeringRVIn vitro antagonism of β-lactam antibiotics by cefoxitinAntimicrob Agents Chemother1982219689756981376
- Clinical and Laboratory Standards InstitutePerformance Standards for Antimicrobial Susceptibility Testing: Eighteenth International SupplementWayne (PA)CLSI2010
- LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT methodMethods20012540240811846609
- LivermoreDMWinstanleyTGShannonKPInterpretative reading: recognizing the usual and inferring resistance mechanisms from resistance phenotypesJ Antimicrob Chemother200148Suppl 18710211420342
- DunneWMJrHardinDJUse of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patients isolates from Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia sppJ Clin Microbiol2005435945594916333080
- PfallerMAJonesRNAntimicrobial susceptibility of inducible AmpC β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997–2000Int J Antimicrob Agents20021938338812007846
- KongKFAguilaASchneperLMatheeKPseudomonas aeruginosa β-lactamase induction requires two permeases, AmpG and AmpPBMC Microbiol20101032821192796
- MushtaqSLivermoreDMAmpC induction by ceftarolineJ Antimicrob Chemother20106526627019996139